Product Details
Minoxidil 7% / Tretinoin 0.025% / Fluocinolone 0.025% / Finasteride 0.2% Hair Spray - 60mL
Manufacturer: The Pharmacy Hub
MFG#: C13565
NDC: C13565
PID: 641044
Additional Information
| Active Ingredients | Minoxidil (7% w/v), Tretinoin (0.025% w/v), Fluocinolone Acetonide (0.025% w/v), Finasteride (0.2% w/v) |
| Dosage Form | Topical Spray Solution |
| Route of Administration | Topical (Scalp) |
| Net Quantity | 60 mL |
| Keep Out of Reach of Children | WARNING: Keep out of reach of children and pets. Accidental ingestion or contact can cause serious harm. This product contains finasteride. Pregnant women or women who may become pregnant must not handle this medication. |
| Contraindications | • Hypersensitivity to any component of the formulation. • Pregnancy, women attempting to conceive, or breastfeeding. • Scalp abrasions, sunburn, or severe inflammation. • History of adverse reactions to topical minoxidil or retinoids. |
| Warnings & Precautions | • Pregnancy Warning (Finasteride): Finasteride is absorbed through the skin and can be absorbed by others through contact. It may cause abnormalities of the external genitalia of a male fetus if absorbed by a pregnant woman. Women who are or may become pregnant must not use this medication and should avoid handling the bottle or contacting the treated scalp. • For topical use on the scalp only. Not for ophthalmic, oral, or intravaginal use. Avoid application to other body areas. • May cause initial, temporary increased hair shedding. • May cause local irritation, dryness, redness, itching, or scaling. Discontinue if severe. • Systemic absorption of corticosteroids can lead to reversible HPA axis suppression. • Use with caution in patients with cardiovascular disease (due to potential systemic minoxidil absorption). |
| Adverse Reactions | Potential adverse reactions include: scalp pruritus, irritation, dryness, flaking, erythema, dermatitis, hypertrichosis (unwanted hair growth on face), tachycardia, dizziness. |
| Drug Interactions | Potential interaction with oral finasteride or other 5-alpha-reductase inhibitors. Use with caution in patients taking antihypertensive medications. |
| Patient Counseling | Advise the patient to: • Read the Medication Guide provided. • Apply to a clean, dry scalp only. • Wash hands thoroughly after application. • Do not allow pregnant women to handle the bottle or touch the treated area. • Allow the spray to dry completely before allowing anyone to make contact with the scalp. • Report any signs of significant irritation, chest pain, dizziness, or rapid heartbeat. |
Description
This is a custom-compounded, prescription-only topical spray formulation designed for the treatment of androgenetic alopecia (pattern hair loss). It combines four active ingredients with complementary mechanisms of action to target multiple pathways involved in hair loss and to potentially enhance the efficacy of minoxidil. This formulation is prepared in a specialized vehicle suitable for spray application to the scalp.
It targets vasodilation, follicular stimulation, inflammation, and DHT inhibition. Allows for easy, precise, and mess-free application to the scalp. This formulation is intended for the treatment of androgenetic alopecia in men and women (unless contraindicated).
- Minoxidil (7%): A vasodilator believed to widen hair follicles and stimulate hair growth by moving follicles into the anagen (growth) phase.
- Tretinoin (0.025%): A retinoid that may enhance the absorption and efficacy of minoxidil. It may also help to normalize follicular keratinization.
- Fluocinolone Acetonide (0.025%): A mid-potency corticosteroid that reduces scalp inflammation and irritation, which can be a contributing factor to hair loss and a side effect of other active ingredients.
- Finasteride (0.2%): A 5-alpha-reductase inhibitor. Topically applied, it aims to suppress the conversion of testosterone to dihydrotestosterone (DHT) directly at the follicular level, potentially minimizing systemic exposure.
Note:
Prepared in a state-licensed, FDA-registered 503B outsourcing facility (or 503A pharmacy). The product is for prescription by licensed healthcare providers only. This product is compounded with drugs that are not FDA-approved for this specific combination, strength, or route of administration. It is provided pursuant to the order of a licensed healthcare professional. Please refer to the critical safety information below, particularly regarding finasteride and pregnancy.
The use of this multi-agent compounded formulation, particularly with topical finasteride, is off-label. It is the responsibility of the prescribing practitioner to ensure the appropriateness for the intended patient based on clinical judgement, to obtain informed consent regarding potential risks (especially teratogenicity), and to provide appropriate patient counseling.
Frequently Asked Questions (FAQs)
The cost of Minoxidil 7% / Tretinoin 0.025% / Fluocinolone 0.025% / Finasteride 0.2% Hair Spray - 60mL is $available for registerd members only
Minoxidil 7% / Tretinoin 0.025% / Fluocinolone 0.025% / Finasteride 0.2% Hair Spray - 60mL is manufactured by The Pharmacy Hub.
You can purchase Minoxidil 7% / Tretinoin 0.025% / Fluocinolone 0.025% / Finasteride 0.2% Hair Spray - 60mL on our website at https://supplies.pipelinemedical.com/product/detail/minoxidil-7-tretinoin-0-025-fluocinolone-0-025-finasteride-0-2-hair-spray-60ml-641044